Smithfield Trust CO Novartis Ag Transaction History
Smithfield Trust CO
- $2 Billion
- Q1 2025
A detailed history of Smithfield Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Smithfield Trust CO holds 980 shares of NVS stock, worth $110,945. This represents 0.01% of its overall portfolio holdings.
Number of Shares
980
Previous 817
19.95%
Holding current value
$110,945
Previous $79,000
37.97%
% of portfolio
0.01%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.34 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.18 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$974 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$799 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$766 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $244B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...